Log in

NASDAQ:APYXApyx Medical Stock Price, Forecast & News

$4.07
-0.37 (-8.33 %)
(As of 06/2/2020 04:00 PM ET)
Add
Compare
Today's Range
$4.07
Now: $4.07
$4.44
50-Day Range
$2.87
MA: $3.72
$4.89
52-Week Range
$2.81
Now: $4.07
$8.59
Volume124,100 shs
Average Volume121,045 shs
Market Capitalization$139.11 million
P/E RatioN/A
Dividend YieldN/A
Beta0.79
Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates through two segments, Advanced Energy and original equipment manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company's Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and the J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.02 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:APYX
CUSIPN/A
CIKN/A
Phone727-384-2323

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$28.15 million
Book Value$2.09 per share

Profitability

Net Income$-19,710,000.00

Miscellaneous

Employees222
Market Cap$139.11 million
Next Earnings Date8/5/2020 (Estimated)
OptionableOptionable

Receive APYX News and Ratings via Email

Sign-up to receive the latest news and ratings for APYX and its competitors with MarketBeat's FREE daily newsletter.

Apyx Medical (NASDAQ:APYX) Frequently Asked Questions

How has Apyx Medical's stock been impacted by COVID-19 (Coronavirus)?

Apyx Medical's stock was trading at $5.06 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, APYX stock has decreased by 19.6% and is now trading at $4.07. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Apyx Medical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apyx Medical in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Apyx Medical.

When is Apyx Medical's next earnings date?

Apyx Medical is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Apyx Medical.

How were Apyx Medical's earnings last quarter?

Apyx Medical Corp (NASDAQ:APYX) announced its quarterly earnings results on Monday, May, 11th. The company reported ($0.20) EPS for the quarter, topping analysts' consensus estimates of ($0.25) by $0.05. The business earned $5 million during the quarter, compared to the consensus estimate of $5.29 million. Apyx Medical had a negative return on equity of 21.45% and a negative net margin of 58.26%. View Apyx Medical's earnings history.

What guidance has Apyx Medical issued on next quarter's earnings?

Apyx Medical issued an update on its first quarter 2020 After-Hours earnings guidance on Monday, March, 16th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $5-5.6 million, compared to the consensus revenue estimate of $7.82 million.

What price target have analysts set for APYX?

2 analysts have issued twelve-month price targets for Apyx Medical's shares. Their forecasts range from $5.00 to $10.00. On average, they anticipate Apyx Medical's stock price to reach $7.33 in the next twelve months. This suggests a possible upside of 80.2% from the stock's current price. View analysts' price targets for Apyx Medical.

Has Apyx Medical been receiving favorable news coverage?

News headlines about APYX stock have trended extremely negative this week, according to InfoTrie Sentiment. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Apyx Medical earned a news sentiment score of -4.6 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutApyx Medical.

Are investors shorting Apyx Medical?

Apyx Medical saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 368,900 shares, a decline of 22.7% from the April 30th total of 477,400 shares. Based on an average trading volume of 101,200 shares, the days-to-cover ratio is currently 3.6 days. Approximately 1.3% of the company's stock are short sold. View Apyx Medical's Current Options Chain.

Who are some of Apyx Medical's key competitors?

What other stocks do shareholders of Apyx Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apyx Medical investors own include Main Street Capital (MAIN), Johnson & Johnson (JNJ), Procter & Gamble (PG), AT&T (T), Wells Fargo & Co (WFC), Amgen (AMGN), Broadcom (AVGO), Alibaba Group (BABA), Bank of America (BAC) and Corbus Pharmaceuticals (CRBP).

Who are Apyx Medical's key executives?

Apyx Medical's management team includes the following people:
  • Mr. Charles D. Goodwin II, Pres, CEO & Director (Age 53)
  • Ms. Tara H. Semb, CFO, Treasurer & Sec. (Age 49)
  • Mr. Moshe Citronowicz, Sr. VP (Age 66)
  • Mr. Todd Hornsby, Exec. VP (Age 43)

What is Apyx Medical's stock symbol?

Apyx Medical trades on the NASDAQ under the ticker symbol "APYX."

Who are Apyx Medical's major shareholders?

Apyx Medical's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (6.55%), State Street Corp (1.75%), Taylor Frigon Capital Management LLC (1.42%), Geode Capital Management LLC (1.22%), Taylor Frigon Capital Management LLC (1.20%) and Cowen AND Company LLC (1.04%). View institutional ownership trends for Apyx Medical.

Which major investors are selling Apyx Medical stock?

APYX stock was sold by a variety of institutional investors in the last quarter, including Silvercrest Asset Management Group LLC, Millrace Asset Group Inc., Morgan Stanley, Cowen Prime Services LLC, State Street Corp, Taylor Frigon Capital Management LLC, and Quilter Plc. View insider buying and selling activity for Apyx Medical.

Which major investors are buying Apyx Medical stock?

APYX stock was acquired by a variety of institutional investors in the last quarter, including Cowen AND Company LLC, JPMorgan Chase & Co., Taylor Frigon Capital Management LLC, Wells Fargo & Company MN, Geode Capital Management LLC, State Board of Administration of Florida Retirement System, Engineers Gate Manager LP, and SG Americas Securities LLC. View insider buying and selling activity for Apyx Medical.

How do I buy shares of Apyx Medical?

Shares of APYX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Apyx Medical's stock price today?

One share of APYX stock can currently be purchased for approximately $4.07.

How big of a company is Apyx Medical?

Apyx Medical has a market capitalization of $139.11 million and generates $28.15 million in revenue each year. The company earns $-19,710,000.00 in net income (profit) each year or ($0.58) on an earnings per share basis. Apyx Medical employs 222 workers across the globe.

What is Apyx Medical's official website?

The official website for Apyx Medical is www.apyxmedical.com.

How can I contact Apyx Medical?

Apyx Medical's mailing address is 5115 Ulmerton Road, Clearwater FL, 33760. The company can be reached via phone at 727-384-2323 or via email at [email protected]

This page was last updated on 6/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.